WuXi Biologics adopt Purolite Life Sciences Protein A resin for monoclonal antibody therapies ...Middle East

PR Newswire - News
WuXi Biologics adopt Purolite Life Sciences Protein A resin for monoclonal antibody therapies
CARDIFF, South Wales, Nov. 5, 2020 /PRNewswire/ -- Purolite Ltd., a global manufacturer of resin-based separation, purification and extraction technologies, today announces that it will supply its Protein A capture resin, Praesto® Jetted A50 to WuXi Biologics for immediate use. WuXi...

Read More Details
Finally We wish PressBee provided you with enough information of ( WuXi Biologics adopt Purolite Life Sciences Protein A resin for monoclonal antibody therapies )

Apple Storegoogle play

Also on site :

Most viewed in News